guardian pharmacy limited Company Information
Company Number
06324300
Website
guardianpharmacymaine.comRegistered Address
c/o john cumming ross ltd, kirkland hse 11-15, peterborough rd, harrow, middlesex, HA1 2AX
Industry
Dispensing chemist in specialised stores
Telephone
02079871398
Next Accounts Due
December 2024
Group Structure
View All
Shareholders
ms seema hassan 25%
mr joe sivadasam 25%
View Allguardian pharmacy limited Estimated Valuation
Pomanda estimates the enterprise value of GUARDIAN PHARMACY LIMITED at £1.5m based on a Turnover of £5.5m and 0.28x industry multiple (adjusted for size and gross margin).
guardian pharmacy limited Estimated Valuation
Pomanda estimates the enterprise value of GUARDIAN PHARMACY LIMITED at £1.1m based on an EBITDA of £279.4k and a 3.9x industry multiple (adjusted for size and gross margin).
guardian pharmacy limited Estimated Valuation
Pomanda estimates the enterprise value of GUARDIAN PHARMACY LIMITED at £344.8k based on Net Assets of £152k and 2.27x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Guardian Pharmacy Limited Overview
Guardian Pharmacy Limited is a live company located in peterborough rd, harrow, HA1 2AX with a Companies House number of 06324300. It operates in the dispensing chemist in specialised stores sector, SIC Code 47730. Founded in July 2007, it's largest shareholder is ms seema hassan with a 25% stake. Guardian Pharmacy Limited is a established, mid sized company, Pomanda has estimated its turnover at £5.5m with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Guardian Pharmacy Limited Health Check
Pomanda's financial health check has awarded Guardian Pharmacy Limited a 2.5 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 7 areas for improvement. Company Health Check FAQs
2 Strong
3 Regular
7 Weak
Size
annual sales of £5.5m, make it smaller than the average company (£12.1m)
- Guardian Pharmacy Limited
£12.1m - Industry AVG
Growth
3 year (CAGR) sales growth of 7%, show it is growing at a faster rate (5.4%)
- Guardian Pharmacy Limited
5.4% - Industry AVG
Production
with a gross margin of 31.9%, this company has a comparable cost of product (31.9%)
- Guardian Pharmacy Limited
31.9% - Industry AVG
Profitability
an operating margin of 2.5% make it less profitable than the average company (3.4%)
- Guardian Pharmacy Limited
3.4% - Industry AVG
Employees
with 54 employees, this is below the industry average (84)
54 - Guardian Pharmacy Limited
84 - Industry AVG
Pay Structure
on an average salary of £22k, the company has an equivalent pay structure (£22k)
- Guardian Pharmacy Limited
£22k - Industry AVG
Efficiency
resulting in sales per employee of £101.3k, this is less efficient (£139.2k)
- Guardian Pharmacy Limited
£139.2k - Industry AVG
Debtor Days
it gets paid by customers after 43 days, this is later than average (31 days)
- Guardian Pharmacy Limited
31 days - Industry AVG
Creditor Days
its suppliers are paid after 55 days, this is quicker than average (69 days)
- Guardian Pharmacy Limited
69 days - Industry AVG
Stock Days
it holds stock equivalent to 27 days, this is in line with average (30 days)
- Guardian Pharmacy Limited
30 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 39 weeks, this is more cash available to meet short term requirements (15 weeks)
39 weeks - Guardian Pharmacy Limited
15 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 93.3%, this is a higher level of debt than the average (61.7%)
93.3% - Guardian Pharmacy Limited
61.7% - Industry AVG
GUARDIAN PHARMACY LIMITED financials
Guardian Pharmacy Limited's latest turnover from March 2023 is estimated at £5.5 million and the company has net assets of £152 thousand. According to their latest financial statements, Guardian Pharmacy Limited has 54 employees and maintains cash reserves of £634.6 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | ||||||||||||||
Other Income Or Grants | ||||||||||||||
Cost Of Sales | ||||||||||||||
Gross Profit | ||||||||||||||
Admin Expenses | ||||||||||||||
Operating Profit | ||||||||||||||
Interest Payable | ||||||||||||||
Interest Receivable | ||||||||||||||
Pre-Tax Profit | ||||||||||||||
Tax | ||||||||||||||
Profit After Tax | ||||||||||||||
Dividends Paid | ||||||||||||||
Retained Profit | ||||||||||||||
Employee Costs | ||||||||||||||
Number Of Employees | 54 | 67 | 53 | 55 | 56 | 69 | 75 | 68 | ||||||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 272,644 | 316,261 | 257,049 | 321,312 | 365,119 | 423,625 | 420,119 | 259,971 | 227,674 | 123,149 | 112,228 | 118,105 | 69,716 | 56,321 |
Intangible Assets | 229,559 | 308,264 | 402,406 | 527,425 | 763,273 | 1,028,288 | 1,293,303 | 1,558,318 | 964,134 | 1,150,444 | 1,336,754 | 1,523,064 | 1,230,803 | 1,300,801 |
Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 100 |
Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Fixed Assets | 502,203 | 624,525 | 659,455 | 848,737 | 1,128,392 | 1,451,913 | 1,713,422 | 1,818,289 | 1,191,808 | 1,273,593 | 1,448,982 | 1,641,169 | 1,300,519 | 1,357,222 |
Stock & work in progress | 282,611 | 182,987 | 252,225 | 271,847 | 148,310 | 189,282 | 170,771 | 122,737 | 97,906 | 103,660 | 98,894 | 81,963 | 52,977 | 53,121 |
Trade Debtors | 645,029 | 627,074 | 621,699 | 674,201 | 609,420 | 588,268 | 551,545 | 478,202 | 572,681 | 568,010 | 512,525 | 501,575 | 305,090 | 256,714 |
Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Misc Debtors | 198,714 | 176,075 | 181,720 | 164,296 | 145,770 | 135,602 | 122,485 | 146,083 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash | 634,576 | 803,552 | 861,121 | 290,536 | 390,228 | 306,844 | 68,928 | 88,466 | 56,600 | 201,871 | 93,290 | 12,706 | 40,893 | 29,668 |
misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current assets | 1,760,930 | 1,789,688 | 1,916,765 | 1,400,880 | 1,293,728 | 1,219,996 | 913,729 | 835,488 | 727,187 | 873,541 | 704,709 | 596,244 | 398,960 | 339,503 |
total assets | 2,263,133 | 2,414,213 | 2,576,220 | 2,249,617 | 2,422,120 | 2,671,909 | 2,627,151 | 2,653,777 | 1,918,995 | 2,147,134 | 2,153,691 | 2,237,413 | 1,699,479 | 1,696,725 |
Bank overdraft | 0 | 0 | 0 | 0 | 122,064 | 122,064 | 1,078,324 | 244,767 | 0 | 0 | 0 | 0 | 0 | 0 |
Bank loan | 87,200 | 93,343 | 91,451 | 122,064 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Creditors | 567,369 | 464,936 | 364,319 | 412,224 | 388,475 | 332,950 | 394,940 | 300,719 | 625,836 | 623,680 | 560,889 | 573,878 | 385,187 | 352,620 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other current liabilities | 174,466 | 304,481 | 388,269 | 86,291 | 152,320 | 211,031 | 368,772 | 259,640 | 0 | 0 | 0 | 0 | 0 | 0 |
total current liabilities | 829,035 | 862,760 | 844,039 | 620,579 | 662,859 | 666,045 | 1,842,036 | 805,126 | 625,836 | 623,680 | 560,889 | 573,878 | 385,187 | 352,620 |
loans | 926,178 | 1,007,236 | 1,102,470 | 1,163,309 | 1,248,284 | 1,307,037 | 0 | 1,078,324 | 442,223 | 375,000 | 375,000 | 300,000 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other liabilities | 300,000 | 375,000 | 375,000 | 375,000 | 375,000 | 375,000 | 375,000 | 375,000 | 516,057 | 753,974 | 913,553 | 1,157,394 | 1,179,874 | 1,302,134 |
provisions | 55,883 | 64,145 | 35,053 | 44,282 | 53,857 | 67,595 | 64,145 | 42,325 | 33,830 | 12,660 | 16,130 | 19,379 | 8,641 | 9,750 |
total long term liabilities | 1,282,061 | 1,446,381 | 1,512,523 | 1,582,591 | 1,677,141 | 1,749,632 | 439,145 | 1,495,649 | 992,110 | 1,141,634 | 1,304,683 | 1,476,773 | 1,188,515 | 1,311,884 |
total liabilities | 2,111,096 | 2,309,141 | 2,356,562 | 2,203,170 | 2,340,000 | 2,415,677 | 2,281,181 | 2,300,775 | 1,617,946 | 1,765,314 | 1,865,572 | 2,050,651 | 1,573,702 | 1,664,504 |
net assets | 152,037 | 105,072 | 219,658 | 46,447 | 82,120 | 256,232 | 345,970 | 353,002 | 301,049 | 381,820 | 288,119 | 186,762 | 125,777 | 32,221 |
total shareholders funds | 152,037 | 105,072 | 219,658 | 46,447 | 82,120 | 256,232 | 345,970 | 353,002 | 301,049 | 381,820 | 288,119 | 186,762 | 125,777 | 32,221 |
Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | ||||||||||||||
Operating Profit | ||||||||||||||
Depreciation | 64,980 | 59,468 | 64,263 | 77,016 | 85,722 | 97,195 | 80,035 | 47,682 | 39,207 | 27,042 | 24,700 | 14,735 | 13,116 | 8,410 |
Amortisation | 78,705 | 94,142 | 125,019 | 235,848 | 265,015 | 265,015 | 285,015 | 192,868 | 186,310 | 186,310 | 186,310 | 170,872 | 69,998 | 69,998 |
Tax | ||||||||||||||
Stock | 99,624 | -69,238 | -19,622 | 123,537 | -40,972 | 18,511 | 48,034 | 24,831 | -5,754 | 4,766 | 16,931 | 28,986 | -144 | 53,121 |
Debtors | 40,594 | -270 | -35,078 | 83,307 | 31,320 | 49,840 | 49,745 | 51,604 | 4,671 | 55,485 | 10,950 | 196,485 | 48,376 | 256,714 |
Creditors | 102,433 | 100,617 | -47,905 | 23,749 | 55,525 | -61,990 | 94,221 | -325,117 | 2,156 | 62,791 | -12,989 | 188,691 | 32,567 | 352,620 |
Accruals and Deferred Income | -130,015 | -83,788 | 301,978 | -66,029 | -58,711 | -157,741 | 109,132 | 259,640 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes & Provisions | -8,262 | 29,092 | -9,229 | -9,575 | -13,738 | 3,450 | 21,820 | 8,495 | 21,170 | -3,470 | -3,249 | 10,738 | -1,109 | 9,750 |
Cash flow from operations | ||||||||||||||
Investing Activities | ||||||||||||||
capital expenditure | ||||||||||||||
Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -100 | 100 |
cash flow from investments | ||||||||||||||
Financing Activities | ||||||||||||||
Bank loans | -6,143 | 1,892 | -30,613 | 122,064 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term loans | -81,058 | -95,234 | -60,839 | -84,975 | -58,753 | 1,307,037 | -1,078,324 | 636,101 | 67,223 | 0 | 75,000 | 300,000 | 0 | 0 |
Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other long term liabilities | -75,000 | 0 | 0 | 0 | 0 | 0 | 0 | -141,057 | -237,917 | -159,579 | -243,841 | -22,480 | -122,260 | 1,302,134 |
share issue | ||||||||||||||
interest | ||||||||||||||
cash flow from financing | ||||||||||||||
cash and cash equivalents | ||||||||||||||
cash | -168,976 | -57,569 | 570,585 | -99,692 | 83,384 | 237,916 | -19,538 | 31,866 | -145,271 | 108,581 | 80,584 | -28,187 | 11,225 | 29,668 |
overdraft | 0 | 0 | 0 | -122,064 | 0 | -956,260 | 833,557 | 244,767 | 0 | 0 | 0 | 0 | 0 | 0 |
change in cash | -168,976 | -57,569 | 570,585 | 22,372 | 83,384 | 1,194,176 | -853,095 | -212,901 | -145,271 | 108,581 | 80,584 | -28,187 | 11,225 | 29,668 |
guardian pharmacy limited Credit Report and Business Information
Guardian Pharmacy Limited Competitor Analysis
Perform a competitor analysis for guardian pharmacy limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.
guardian pharmacy limited Ownership
GUARDIAN PHARMACY LIMITED group structure
Guardian Pharmacy Limited has no subsidiary companies.
Ultimate parent company
GUARDIAN PHARMACY LIMITED
06324300
guardian pharmacy limited directors
Guardian Pharmacy Limited currently has 2 directors. The longest serving directors include Mr Andrew Ng (Jul 2007) and Mr Joe Sivadasam (Apr 2008).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Andrew Ng | 58 years | Jul 2007 | - | Director | |
Mr Joe Sivadasam | 49 years | Apr 2008 | - | Director |
P&L
March 2023turnover
5.5m
-3%
operating profit
135.8k
0%
gross margin
32%
-0.78%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2023net assets
152k
+0.45%
total assets
2.3m
-0.06%
cash
634.6k
-0.21%
net assets
Total assets minus all liabilities
Similar Companies
guardian pharmacy limited company details
company number
06324300
Type
Private limited with Share Capital
industry
47730 - Dispensing chemist in specialised stores
incorporation date
July 2007
age
17
accounts
Total Exemption Full
ultimate parent company
previous names
N/A
incorporated
UK
address
c/o john cumming ross ltd, kirkland hse 11-15, peterborough rd, harrow, middlesex, HA1 2AX
last accounts submitted
March 2023
guardian pharmacy limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 10 charges/mortgages relating to guardian pharmacy limited. Currently there are 3 open charges and 7 have been satisfied in the past.
guardian pharmacy limited Companies House Filings - See Documents
date | description | view/download |
---|